{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:00:39Z","timestamp":1776686439181,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.abd.2026.501298","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:20:10Z","timestamp":1773912010000},"page":"501298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ki-67 staining pattern as a prognostic biomarker for advanced acral melanoma"],"prefix":"10.1016","volume":"101","author":[{"given":"Marcel Arakaki","family":"Asato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabeli Joaquim","family":"Contel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Alves","family":"Moraes Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Polizel","family":"Ocanha-Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia Silva Carlos","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell A.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela Esther Alencar","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-419X","authenticated-orcid":false,"given":"Jos\u00e9 C\u00e2ndido Caldeira","family":"Xavier-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501298_bib0005","first-page":"63","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med Sci"},{"key":"10.1016\/j.abd.2026.501298_bib0010","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3390\/cancers12092508","article-title":"Insights into differentiation of melanocytes from human stem cells and their relevance for melanoma treatment","volume":"12","author":"Mirea","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.abd.2026.501298_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American joint committee on cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.abd.2026.501298_bib0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2026.501298_bib0025","volume":"vol. 12","year":"2025"},{"key":"10.1016\/j.abd.2026.501298_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","article-title":"Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients","volume":"143","author":"Kuchelmeister","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2026.501298_bib0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjsurg.2012.05.013","article-title":"Unique prognostic factors in acral lentiginous melanoma","volume":"204","author":"Egger","year":"2012","journal-title":"Am J Surg"},{"key":"10.1016\/j.abd.2026.501298_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2026.501298_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5858\/arpa.2014-0075-RA","article-title":"Immunohistochemistry in dermatopathology","volume":"139","author":"Ferringer","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.abd.2026.501298_bib0050","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.abd.2026.501298_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.abd.2026.501298_bib0060","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1200\/JCO.2005.02.0735","article-title":"Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma","volume":"23","author":"Gimotty","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.abd.2026.501298_bib0065","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.10685","article-title":"Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma","volume":"95","author":"Hazan","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.abd.2026.501298_bib0070","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/cup.14495","article-title":"PRAME expression in cutaneous melanoma does not correlate with disease\u2010specific survival","volume":"50","author":"Parra","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2026.501298_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAI.0000000000000530","article-title":"Expression of Ki-67 and estrogen receptor beta in primary cutaneous melanoma as a potential indicator of regional lymph node positivity","volume":"27","author":"Udovicic-Gagula","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.abd.2026.501298_bib0080","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2026.501298_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.abd.2026.501298_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1242\/jcs.92.4.531","article-title":"Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. localization in mitotic cells and association with chromosomes","volume":"92","author":"Verheijen","year":"1989","journal-title":"J Cell Sci"},{"key":"10.1016\/j.abd.2026.501298_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1091\/mbc.e16-09-0659","article-title":"The p150N domain of chromatin assembly factor-1 regulates Ki-67 accumulation on the mitotic perichromosomal layer","volume":"28","author":"Matheson","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.abd.2026.501298_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00428-020-03010-4","article-title":"A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues","volume":"479","author":"Dias","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.abd.2026.501298_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/cup.14604","article-title":"Eosinophils in psoriasis: a systematic review and meta-analysis introducing a study quality assessment tool for diagnostic pathology studies","volume":"51","author":"Caro-Chang","year":"2024","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.abd.2026.501298_bib0110","series-title":"A Proposal for strength-of-agreement criteria for lin\u2019s concordance correlation coefficient","author":"McBride","year":"2005"},{"key":"10.1016\/j.abd.2026.501298_bib0115","series-title":"AJCC Cancer staging manual","author":"Macro- Edge","year":"2010"},{"key":"10.1016\/j.abd.2026.501298_bib0120","article-title":"Prognostic and clinicopathological value of Ki-67 in melanoma: a meta-analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.abd.2026.501298_bib0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6600458","article-title":"Targeting the cell cycle for cancer therapy","volume":"87","author":"Carnero","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.abd.2026.501298_bib0130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/exd.13303","article-title":"Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities","volume":"26","author":"Haass","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2026.501298_bib0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jid.2016.02.805","article-title":"Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells","volume":"136","author":"Beaumont","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2026.501298_bib0140","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1038\/s41467-023-39122-z","article-title":"Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects","volume":"14","author":"Gross","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.abd.2026.501298_bib0145","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","article-title":"Targeting the cell cycle: a new approach to cancer therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:16:13Z","timestamp":1776683773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0365059626000115"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501298","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ki-67 staining pattern as a prognostic biomarker for advanced acral melanoma","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501298"}}